Posted by AGORACOM
at 8:38 AM on Monday, December 14th, 2020
Toronto, Ontario–(Newsfile Corp. – December 14, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland“), and Disruptive Pharma, a Latin American focused pharmaceutical investment company, are pleased to announce they have entered into a non-binding letter of intent for the purposes of creating a joint venture to cultivate, manufacturer, and commercialize magic truffles for the Brazilian market and to explore other potential business opportunities, subject to compliance with all applicable laws and regulations of Brazil, home to more than 200 million people.
Disruptive Pharma is focused on developing innovative solutions for the health and wellness industry and is a principal investor in Mundihealth.com (MundiHealth), a US based company and the owner of MyPharma2GO.com (MyPharma2Go), a large prescribed medicines website distributing to Brazil and Latin America. MundiHealth.com also has exclusive distribution agreements with some of the largest and most well established vitamin and supplement brands in the world.
“Brazil’s market is huge and we are pleased to enter into this LOI with Disruptive Pharma, with the opportunity to leverage their entire portfolio of companies including MyPharma2Go.com, a large Brazilian online pharmaceutical and supplement distributor,” said Todd Shapiro, CEO and Director of Red Light Holland. “We look forward to bringing our knowledge in growing Magic Truffles for the purposes of cultivating, manufacturing, and distributing in Brazil, while we continue to build our Red Light Holland Brand, sell our iMicrodose packs, and expand our e-commerce strategies.”
Red Light Holland’s intention is to leverage Disruptive Pharma’s proven distribution and health technology experience with their proven knowledge in growing magic truffles. The two company’s visions align as both Red Light Holland and Disruptive Pharma believe in providing responsible access to products that have the potential to enhance quality of life, especially for those in need of innovative treatments and those who have not succeeded with traditional medicines. Red Light Holland and Disruptive Pharma will carefully explore the legalities of magic truffles and magic mushroom products in Brazil and further details of the proposed joint venture will be announced once available.
About MyPharma2GO
In Brazil and other LatAm countries, specific legislation permits consumers to import medicines, medical devices, OTCs and health products. Established in 2018 and headquartered in the US, Mundihealth / MyPharma2Go uses this legislation to bring HCP-focused pharmaceuticals and/or B2C supplements towards the region. By contracting MP2Go’s business services, companies can launch products within 30 days following agreement, legally sidestepping a 1-3 year registration process with Health Authorities, anticipating revenue and testing the market without committing high monetary investment. Once the prescription has been generated and the product purchased, MP2Go dispatches it from its FDA-approved warehouse in Florida, Netherlands or Israel via its proprietary courier service. This permits full tracking of the items, which are delivered directly to the consumer in 7-10 business days under full compliance of Health Authorities and Customs. Customer Care is also a priority for the company, covering all aspects of the HCP and patient/consumer journeys aiming recurrence and solid growth for all brands allied to great user experience.
About Red Light Holland Corp.
Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
Posted by AGORACOM
at 8:33 AM on Monday, December 14th, 2020
Gratomic Inc. (“GRAT” or the “Company”) (TSXV:GRAT)(FSE:CB81)(WKN:A143MR)(OTCQB:CBULF) wishes to announce that its common shares have been approved for trading on the OTCQB Venture Market in the United States under the symbol (OTCQB:CBULF). Trading commences on Monday December 14, 2020. Investors in the US can find current financial disclosure and Real-Time Level 2 quotes in US currency for Gratomic on www.otcmarkets.com. The common shares of the Company are DTC eligible to facilitate trading, settlement and clearance in the US.
About Gratomic Inc. Established in 2014, Gratomic is an advanced materials company focused on low-cost mine to market commercialization of carbon-neutral, Eco-friendly, high purity vein graphite and is set to become a key player in EV and Renewable Resource supply chains. Gratomic Inc. is a leader among peers, anticipating full operational capabilities in late 2020 and aiming to transition to an open pit operation as early as the end of 2021.
Gratomic is in the process of solidifying its development plans for micronization and spheronization of its clean Aukam graphite. This significant milestone is a small, additional step in the Company’s existing Eco-friendly processing cycle and will allow its naturally high purity graphite to meet ideal North American battery grade standards for use in Li-ion battery anodes.
The Company promises to deliver mine-to-market traceability and guaranteed quality control. This will be accomplished by providing documented tracking on all graphite generated at its flagship Aukam Graphite Project. The tracking will begin at Aukam and will be verified at every stage during transport.
Two off-take purchase agreements are currently held for lump-vein graphite sourced from Gratomic’s Aukam Graphite Project in Namibia, Africa. Fulfillment of the contracts is slated to begin in 2021. The agreements exist with TODAQ and Phu Sumika.
TODAQ is an innovative tech company and will partner with Gratomic on its mine-to-market commodity tracking.
Phu Sumika is a large global graphite supplier to battery and lubrication companies.
Gratomic Inc. is listed on the TSX Venture Exchange under the symbol GRAT.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 8:27 AM on Monday, December 14th, 2020
A 400% increase in cultivation and production capacity is expected as they expand into their new facility
“This facility is going to resonate through the industry, not only in California, but I believe worldwide,” says CEO, Bob Blink.
TransCanna Holdings seeks to contribute to the cannabis industry as a strategic vertically integrated acquisition company. TransCanna is currently transforming. They’re now scaling the company to leverage their vertically integrated cannabis facility in Modesto California. In fact, it will be one of the largest cannabis facilities in the State. It will also have access to over 39 million residents and 240 million visitors per year. Further, the facitlity will be over 20 times larger than their current site.
“We’re really excited about phase one financing because it’s going to enable us to realize a four hundred percent increase in cultivation and production capacity,” says General Manager, Alan Applonie.
All of TransCanna’s product in its original site is sold out until March of 2021. So, bringing this additional capacity online will allow the company to deliver the product to consumers.
“With Phase One expansion plans nearly complete, TransCanna is prepared to seize on some massive opportunities,” says Blink.
In addition, the company recently acquired two California companies, a high-end edible producer Soldaze and a premium indoor cultivator and distributer Lyfted Farms. Combining one of the largest cannabis production facilities with the brands and management teams from these acquisitions will make TransCanna a major opportunity for investors and partners alike.
Posted by AGORACOM
at 8:25 AM on Monday, December 14th, 2020
Vancouver, British Columbia–(Newsfile Corp. – December 14, 2020) – Fabled Silver Gold Corp. (TSXV: FCO) (“Fabled” or the “Company“) is pleased to announce the completion of the first ever ground geophysical survey on the Santa Maria Property, in Parral, Mexico and subsequent commencement of drilling. Fabled’s management team strongly believes that the Santa María Property is an under-explored, high-grade silver-gold project with significant exploration potential to expand mineral resources and identify new discoveries.
The first phase of drilling will consist of a minimum of 8,000 meters of HQ size core with a Versadrill 1.4 mount track. Drilling is expected to define the Santa Maria veining at depth and to the east and west using the IP anomalies as a target. This will be followed by pure exploration to test virgin IP targets to the north of the property, as identified by the recent survey. Fabled has awarded the surface diamond drill contract to Maza Diamond Drilling SA DE CV.
Peter J. Hawley, CEO and President remarks: “This is the first ever detailed geophysical survey on the property and has successfully identified multiple targets for exploration and drilling, which continues to support our theory of not only multi phases of mineralization but the relationship to structural controls. The results have been incorporated into surfacing mapping, sampling and underground and surface drilling resulting in a new theory of mineralizing events which should enhance our exploration success. Over four years past owners have only drilled approximately 9,600 meters and we are embarking on an initial 8,000-meter program to determine the true potential of the property, which is expected to take five months to complete.”
A video summary of today’s news release is available here.
Geophysical Interpretation and Survey Results
A 3-Dimensional Instantaneous Potential, (“IP”) survey covered the entire property at 50-meter line spacing and was 16 blocks in size with penetration to -500 meters minimum. The complete survey resulted in pseudo sections with 2D inversion for each line, a property plan map for chargeability and resistivity; and interpretative map with axis of anomalies and a Voxel 3-Dimensional model.
In addition, 27 kilometers of ground magnetics was completed over the property resulting in a final product consisting of a topographic plan map, total field, first derivative and reduced to the pole and 3D inversion magnetics.
A total of 11 first priority IP targets have been delineated property wide (see Figure 1 below), which are in a generalized east – west direction. Anomaly IPSM-1 located 400 meters to the east of the last surface expression of the Santa Maria Veins is defined as sub-cropping, (very shallow) and an extension of the Santa Maria veining. All other IP anomalies define new trends in the northern sector and range from shallow in depth to deep seated, +/- 100-150 meters in depth. The deeper anomalies are described as wide bodies in the areas where they intersect the secondary mineralized north – south veining. The geological team has collected 26 surface samples over all anomalies, and these have been submitted to ALS Chihuahua Laboratory for analysis.
Fabled’s reinterpretation of the age and mineralizing events and structures on the Santa Maria property finds that the Santa Maria and Santa Maria dos veins are hosted in a primary generalized east – west trending rhyolite zone and mineralization consists of silver and gold only. Younger Parral formation, post mineralization, sediments overlay the vein trends to the west, east, and in the north of the property.
These sediments have been structurally stressed / sheared in a generalized north – south trend as a result of the San Rafael graben northeast of the property, a major tectonic feature that has a regional effect of the placement of mineralization. These structures not only slightly offset the east – west trending Santa Maria Veins but wide zones of hydrothermal breccias are encountered where the intersection occurs. These north – south trending structures are interfiled with calc silicate veining which surface sampling has determined they not only contain silver – gold values but also lead, zinc, and copper. This has been interpreted to be a second mineralizing event.
Structure on structure creating dialization zones consisting of hydrothermal breccias have been reported in drill hole SM18-03 which reported 43.35 meters grading 0.78 g/t Au, 232.89 g/t Ag including a section reporting 3.35 g/t Au, 1,1012.63 silver over 8.94 meters.
About Fabled Silver Gold Corp.
Fabled is focused on acquiring, exploring and operating properties that yield near-term metal production. The company has an experienced management team with multiple years of involvement in mining and exploration in Mexico. The company’s mandate is to focus on acquiring precious metal properties in Mexico with blue-sky exploration potential.
The company has entered into an agreement with Golden Minerals Company to acquire the Santa Maria project, a high-grade silver-gold property situated in the centre of the Mexican epithermal silver-gold belt. The belt has been recognized as a significant metallogenic province, which has reportedly produced more silver than any other equivalent area in the world.
For further information please contact:
Mr. Peter J. Hawley, President and C.E.O. Fabled Silver Gold Corp. Phone: (819) 316-0919 [email protected]
Posted by AGORACOM-JC
at 7:41 AM on Monday, December 14th, 2020
Announced a follow-on order for approximately C$ 1.1 million with a key U.S. military customer to expand use of the Company’s TASCS IFM system in military exercises, a key precursor to wider adoption
contract is for application of the TASCS IFM system on the 81mm mortar platform, which transforms it into a “smart” weapon system with greater accuracy and faster response time, improving soldier survivability and operational effectiveness.
Work under the order is scheduled to commence immediately.
Founder, President and CEO Jeff MacLeod commented that, “This marks another key validating milestone in a market where TASCS IFM on the 81mm mortar alone could ultimately be worth up to C$120 million in the U.S. and another C$400 million worldwide, given the large installed base of 81mm mortars in service with so many NATO and allied military forces.”
Ottawa, Ontario–(December 14, 2020) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced a follow-on order for approximately C$ 1.1 million with a key U.S. military customer to expand use of the Company’s TASCS IFM system in military exercises, a key precursor to wider adoption.
The contract is for application of the TASCS IFM system on the 81mm mortar platform, which transforms it into a “smart” weapon system with greater accuracy and faster response time, improving soldier survivability and operational effectiveness. Work under the order is scheduled to commence immediately.
KWESST Founder, President and CEO Jeff MacLeod commented that, “This marks another key validating milestone in a market where TASCS IFM on the 81mm mortar alone could ultimately be worth up to C$120 million in the U.S. and another C$400 million worldwide, given the large installed base of 81mm mortars in service with so many NATO and allied military forces.”
KWESST previously announced the completion of an earlier two-phase initial contract with the same customer that marked the introduction of TASCS IFM on 81mm mortars in military exercises. “It is very encouraging to see the accelerated pace at which this important customer is expanding the use of TASCS IFM in its field exercises, and their confidence in KWESST,” added MacLeod. “It is an honor to be working with them to enhance soldier survivability and effectiveness, which is our core mission.”
As previously announced, the TASCS IFM system has attracted interest from other NATO forces who have requested proposals from KWESST, which the Company is currently actioning. “The fact that the TASCS IFM confers so many modernization advantages without any modification to weapon platforms or munitions is a huge attraction,” said MacLeod.
He added that, “The 81mm mortar is just one of many different weapon platforms that can be transformed into a smart system with TASCS IFM, providing soldiers on the ground with real-time networked situational awareness and precision targeting information.” Accordingly, KWESST is pursuing additional global markets for the TASCS IFM, which can also work on platforms such as: 60mm mortars; grenade launchers; sniper rifles; drones; electronic decoys; and more, with a total addressable market of more than C$1 billion.
About KWESST
KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous GreyGhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE.
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the plans and operations of KWESST. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Posted by AGORACOM-JC
at 7:37 AM on Monday, December 14th, 2020
Film Bubble Provides Another Major Opportunity As Spin-Off Of Successional NCAA Venue Bubble and Travel Bubble Projects
Announced the successful launch of its first “Film Bubble” for a major motion picture (“MMP1”) that is scheduled to commence filming in January 2021.
The name of the film and the starring actors will remain confidential until the commencement of filming.
launch of the Film Bubble for MMP1 is the result of a partnership agreement with Draganfly Inc (DFLY:CSE).
Draganfly’s Safe Set Solutions for the global film and TV production industry is a ground-based technology that uses symptom pre-screening, elevated body temperature measurement, and social distancing digital display to help ensure that everybody on the set is safe.
VANCOUVER, British Columbia, Dec. 14, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the successful launch of its first “Film Bubble” for a major motion picture (“MMP1”) that is scheduled to commence filming in January 2021. The name of the film and the starring actors will remain confidential until the commencement of filming.
The launch of the Film Bubble for MMP1 is the result of a partnership agreement with Draganfly Inc (DFLY:CSE). Draganfly’s Safe Set Solutions for the global film and TV production industry is a ground-based technology that uses symptom pre-screening, elevated body temperature measurement, and social distancing digital display to help ensure that everybody on the set is safe.
Loop Insights CEO Rob Anson stated, “The addition of Dragonfly’s Safe Set Solutions to our Venue Bubble Platform creates an instant and powerful Film Bubble solution for an industry that has suffered catastrophic losses in 2020 and can’t afford to stay shut down for a minute longer. We are extremely proud to have jointly delivered a solution to the film industry that will allow them to safely get their crews, actors, and supporting infrastructure back to work and generating prosperity, the ripple effects of which reverberate around the world.”
Draganfly CEO Cameron Chell stated, “Partnering with Loop Insights to combine our respective technologies into Loop’s Venue Bubble solution is a powerful and significant step to help all industries and most immediately Hollywood and the global film industry safely ramp up production. Film industry investors, insurance companies, unions, and guilds are all seeking this type of solution to keep workers safe and protect their investments.”
FILM AND TV STUDIOS SEEK FAST AND RELIABLE TESTING SOLUTIONS TO RESUME SAFE OPERATIONS AND MITIGATE BILLIONS IN LOSSES
Total earnings at the North American box office in 2019 amounted to $USD 11.32 billion according to Statista.com . In January 2020, the U.S. motion picture and sound recording industry employed over 456 thousand people, with several hundred thousand more in Canada, the U.K., and around the world.
As a result of production closures and cinema shutdowns related to COVID-19, the majority of the industry’s revenues and jobs have been temporarily lost and are now at significant risk of long-term damage if the industry is unable to find solutions that can provide for the safe resumption of operations.
Specifically, the global entertainment industry is projected to lose a staggering $160 billion of growth over the next five years, according to research firm Ampere Analysis .
On November 2nd, AMC Theatres announced a 91% drop in revenues during the most recent earnings period, with losses hitting $906 million in just this quarter.
LOOP AND DRAGANFLY FILM BUBBLE POSITIONED TO DELIVER INDUSTRY-LEADING SOLUTION
“With the whole world watching, including professional sports leagues and teams, college sports leagues and teams, world-renown venues and hospitality companies, Loop hit it out of the park and provided the world with the empirical data necessary to demonstrate our bubble solution is nothing short of world-class.”
Draganfly’s Vital Intelligence technology utilizes regular cameras to read vital signs such as Heart Rate, Respiratory Rate, and Sp02. The technology can help screen for infectious conditions, including COVID-19. The technology has been deployed on Drones and in Kiosks, along with an initial mobile API that has been implemented with several pilot customers.
Loop CEO Rob Anson added, “The film industry has been an obvious major opportunity for our Venue Bubble solution and this first Film Bubble will provide a great showcase for our film industry solution, as well as, additional opportunities for travel, venue, and various healthcare applications we have been working on.”
Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge and software and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.
About Loop Insights
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 7:32 AM on Monday, December 14th, 2020
Announce the receipt of in excess of $5,500,000 from the exercise of warrants up to December 11, 2020
The proceeds were received over the past four trading days as a result of strong equity market support for the momentum demonstrated by the Company
It serves as an indication of the strength of Empower’s shareholder base and its following
Company is pleased to report that our new website has been launched to reflect the Company’s pillars of growth in 2021 and beyond
VANCOUVER BC / December 14, 2020 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through its clinics, telemedicine platforms and as a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and validating novel COVID-19 testing protocols for CE, FDA and Health Canada approval is pleased to announce the following:
RECEIPT OF $5,500,000 + FROM THE EXERCISE OF WARRANTS ALLOWS EMPOWER TO CONTINUE TO EXECUTE WITH INCREASED STRENGTH
Empower is pleased to announce the receipt of in excess of $5,500,000 from the exercise of warrants up to December 11, 2020. The proceeds were received over the past four trading days as a result of strong equity market support for the momentum demonstrated by the Company. It serves as an indication of the strength of Empower’s shareholder base and its following.
The Company expects to generate meaningful revenue from its current and anticipated sales pipeline over the next 12 months, as well as, receive additional proceeds from further anticipated warrant exercises, the Company is confident it has the war chest necessary to pursue numerous opportunities. KAI medical laboratory continues to expand nationwide in the U.S., Empower is growing physician services and direct access to patients through new clinics expansions and the company will provide dynamic technology-based healthcare services to meet patient needs.
Steven McAuley, Chairman and CEO of Empower stated, “The timing of these warrant exercises could not be better as we head into our biggest growth phase ever, thanks to rapidly growing demand for our KAI Medical Lab COVID-19 testing solutions, as well as, the impending launch of our FDA approved KAI Saliva Test plus the pending clinic group acquisition in Canada. These proceeds significantly bolster our financial strength, resources and confidence necessary to aggressively pursue our growth strategies in 2021.”
EMPOWER LAUNCHES NEW WEBSITE TO BETTER REFLECT COMPANY’S 2021 DIRECTION
The Company is pleased to report that our new website has been launched to reflect the Company’s pillars of growth in 2021 and beyond, as well as, our defined vision as follows:
GROWTH PILLARS
Health & Wellness Is Our Purpose – Through our clinics in the US and telemedicine platform, our physicians treat patients in Oregon, Arizona and Washington State. Within this section you can read our statements about integrated care and patient first care.
Diagnostics & Tech Is Our Vision – The October 5th acquisition of Texas-based KAI Medical Laboratory was a significant achievement for Empower, as it firmly and immediately established the science and research side of Empower. In its first month, KAI delivered record revenues and soon after announced its first $1,000,000 COVID-19 testing contract for a major film and television studio.
This section is rich in information for investors that want to better familiarize themselves with the capabilities of KAI Laboratory and COVID-19 testing capabilities that attracted major contracts and R&D initiatives.
EMPOWER TO COMMENCE VERIFIED DISCUSSIONS BY CEO AND KEY PERSONNEL ON AGORACOM
The Company is commencing discussions on its “CEO Verified Forum” on AGORACOM, which is intended to serve as one of the Company’s social media platforms for interaction with current and prospective shareholders.
Steven McAuley added “The growth experienced by Empower over the past 12 months has come from all sources providing the best possible engagement with our clients, followers, investors and all social platforms. I enjoy responding to shareholder inquiries, and the demand for engagement and discussion by investors has grown significantly. Engaging with Agoracom followers is an invaluable tool given our anticipated developments and I look forward to posting my comments and interactions with shareholders.”
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients and provide long term value for our shareholders.
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley’s franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
Posted by AGORACOM-JC
at 7:27 AM on Monday, December 14th, 2020
Announces that it will begin to publicly disclose unaudited net asset value per share on a monthly basis, commencing with the January 31, 2021 period.
This expands on ThreeD’s established practice of releasing NAV on a quarterly basis and reflect our response to shareholder interest in receiving NAV information more frequently.
TORONTO, Dec. 14, 2020 – ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF) announces that it will begin to publicly disclose unaudited net asset value per share (“NAV”) on a monthly basis, commencing with the January 31, 2021 period. This expands on ThreeD’s established practice of releasing NAV on a quarterly basis and reflect our response to shareholder interest in receiving NAV information more frequently.
Monthly NAV will be disclosed by the Company in a press release and be available on the Company’s website approximately 15 days after month-end. NAV will be calculated based on unaudited month-end financial information.
NAV is a non-GAAP measure calculated as the value of total assets less the value of total liabilities divided by total number of common shares outstanding, as at a specific date. The term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies.
“ThreeD believes that providing monthly NAV updates, will be beneficial to our shareholders by providing information that is useful to understanding our performance”, states Sheldon Inwentash, Chairman and CEO, “This measure will help provide a benchmark to evaluate our business relative to that of our peers”.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
For further information: Gerry Feldman, CPA, CA Chief Financial Officer and Corporate Secretary [email protected] Phone: 416-941-8900 ext 106
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to timing and content of future disclosures of the NAV of the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur including, without limitation, risks relating to the timing and content of future public disclosures by the Company or related to the fact that the term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
Posted by AGORACOM-JC
at 3:38 PM on Friday, December 11th, 2020
Hollister Biosciences Inc. (HOLL:CSE) (HSTRF:OTC) (HOB: FRANKFURT) is a multi-state cannabis company with products in 230 dispensaries throughout California and over 80 dispensaries throughout Arizona, translating into the following great success:
REVENUES $CAD
Q1 $1,200,000
Q2 $11,500,000
Q3 $12,500,000
NOTE: Venom Extracts Acquisition Closed at the end of Q1.
TOTAL Q1/Q2/Q3
REVENUE $25.2M
On December 9 th, 2020, Venom achieved the second and final revenue milestone by generating in excess of CDN$40,000,000 of revenue calculated from January 1 st, 2020.
With the recent passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona Hollister is extremely well positioned to capitalize. This can best be summed up by quote of Venom Extracts Founder below:
“Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024 1 , significantly expanding the total addressable market for Cannabis in the state. We look forward to making our product line available to both the medical and recreational end user.” Shared Jacob Cohen, Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona
In addition to organic sales, Hollister has several high-level partnerships that demonstrate how trusted the Company is within the industry, including:
Posted by AGORACOM-JC
at 3:12 PM on Friday, December 11th, 2020
Avicanna (AVCN: TSX) (AVCN: OTCQX) (0NN: FSE) is a vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global marketplace.
Third Quarter Highlights
$882K in revenue, an increase of 24% from Q2-2020,
Double-digit growth, quarter over quarter from Q4-2019
In addition, the Company was able to reach a major milestone with the launch of certain products from its RHO Phyto product line in Canada and further diversified its revenue streams.
When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products as follows:
1. The company has a full line of high end CBD based skin care products serving the consumer retail segment with Canadian distribution through Medical Cannabis by Shoppers, as well as global distribution later this year.
2. Avicanna’s superior medical cannabis line also features products distributed through Medical Cannabis by Shoppers, the online arm of Canada’s largest drugstore chain.
Recently Launched Medical Cannabis Program with its RHO Phyto™ Formulary Nationwide in Colombia (Read More)
Leveraging thesuccessful launch ofthe Company’sRHO Phyto™brandedadvancedmedical cannabisproduct linein Canada,the portfolio of preparations,including oil drops, sublingual sprays, capsules and topicals,are nowavailablenationwide inColombia through physician prescription.
The medical programincludesAvicanna’s 3pillarsaimed at setting the gold standard for medical cannabis in Colombia andotherLatin American markets, including
3. Avicanna also hosts a full pipeline of Pharmaceuticals in various stages of trials to address Dermatology, Psychiatry, Neurology, Pain and Oncology. Three of the company’s products are already as far as phase 2.
